Researchers Identify Key Compounds to Resolve Abnormal Vascular Growth in Age-Related Macular Degeneration
August 21, 2017
August 21, 2017
BOSTON, Aug. 21 -- Massachusetts Eye and Ear issued the following news release:
A compound of specific bioactive products from a major family of enzymes reduced the severity of age-related macular degeneration (AMD) in a preclinical model, according to a new study led by Massachusetts Eye and Ear researchers. The report, published online today in the Proceedings of the National Academy of Sciences, suggests that it may be possible to prevent the vision loss resulting from disease-ca . . .
A compound of specific bioactive products from a major family of enzymes reduced the severity of age-related macular degeneration (AMD) in a preclinical model, according to a new study led by Massachusetts Eye and Ear researchers. The report, published online today in the Proceedings of the National Academy of Sciences, suggests that it may be possible to prevent the vision loss resulting from disease-ca . . .